36 results
8-K
EX-99.1
ACST
Acasti Pharma Inc - Ordinary Shares
27 Jun 24
Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial
4:10pm
, annual cases of aSAH are estimated at approximately 60,000 in the European Union, and approximately 150,000 in China.
About the GTX-104
GTX-104
8-K
EX-99.1
ACST
Acasti Pharma Inc - Ordinary Shares
21 Jun 24
Acasti Announces Year-End 2024 Financial Results, Provides Business Update
8:00am
on market research. Outside of the United States, annual cases of aSAH are estimated at approximately 60,000 in the European Union, and approximately 150,000
8-K
EX-99.1
ACST
Acasti Pharma Inc - Ordinary Shares
12 Feb 24
Acasti Announces Third Fiscal Quarter 2024 Financial Results and Business Highlights
8:00am
Union, and approximately 150,000 in China.
About Acasti
Acasti is a late-stage biopharma company with drug candidates addressing rare and orphan
424B3
cyfc ky8p97ulpwzcnji
16 Oct 23
Prospectus supplement
4:31pm
8-K
EX-10.1
xqmtik6r6ootfi
26 Sep 23
Acasti Announces $7.5 Million Private Placement Equity Financing
8:10am
424B5
wwrt9d1a
10 Nov 21
Prospectus supplement for primary offering
7:23am
424B3
tvguf
15 Jul 21
Prospectus supplement
4:45pm